Nojima Yuhei, Nanto Shinsuke, Adachi Hidenori, Ihara Madoka, Kurimoto Tetsuya
Department of Cardiology, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan.
Case Rep Cardiol. 2017;2017:8632747. doi: 10.1155/2017/8632747. Epub 2017 Jul 9.
A new reentry device (Outback Elite) system has been available in Japan since June 2016. This new device enables easier treatment of chronic total occlusion (CTO) in the lower extremities. We report a case of a woman in her 70s who underwent revascularization using this new device twice to treat both of her femoropopliteal CTO lesions. She was referred to our hospital complaining of intermittent claudication in both legs. She had a long history of diabetes mellitus complicated with severe chronic kidney disease. Her estimated glomerular filtration rate was <20. She refused surgical revascularization; therefore, we performed our treatment without iodine contrast medium. First, magnetic resonance imaging was performed to confirm that the CTO lesions had caused severe claudication before intervention. Subsequently, the Outback Elite device and carbon dioxide (CO) angiography made it possible to revascularize both of her legs without iodine contrast medium. At 6 months after the procedures, we did not observe exacerbation of claudication in her legs.
一种新型再入路装置(Outback Elite)系统自2016年6月起在日本上市。这种新装置使下肢慢性完全闭塞(CTO)的治疗更加简便。我们报告一例70多岁女性患者,使用这种新装置进行了两次血管重建术,以治疗其双侧股腘动脉CTO病变。她因双下肢间歇性跛行前来我院就诊。她有长期糖尿病病史,并发严重慢性肾脏病。她的估计肾小球滤过率<20。她拒绝手术血管重建;因此,我们在不使用碘造影剂的情况下进行了治疗。首先,进行磁共振成像以确认CTO病变在干预前已导致严重跛行。随后,Outback Elite装置和二氧化碳(CO)血管造影使得在不使用碘造影剂的情况下对她的双腿进行血管重建成为可能。术后6个月,我们未观察到她双下肢跛行加重。